Literature DB >> 8835322

Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy.

M Eto1, K Horita, A Morikawa, H Nakata, M Okada, M Saito, M Nomura, A Abiko, Y Iwashima, A Ikoda.   

Abstract

The genetic polymorphism of apolipoprotein E (epsilon 2, epsilon 3 and epsilon 4) is associated with lipid abnormalities. It has been suggested that lipid abnormalities may contribute to the development and progression of kidney diseases, including diabetic nephropathy. Thus, in this study we compared the apo E allele frequencies among 146 non-insulin-dependent diabetic (NIDDM) patients with nephropathy, 135 NIDDM patients without nephropathy and 576 of the general Japanese population. The epsilon 2 allele frequency was significantly higher in diabetic patients with nephropathy (7.2%) and with renal failure (9.7%) than in diabetic patients without nephropathy (2.6%) and in the general Japanese population (3.7%). It is concluded that there is a possibility that the epsilon 2 allele is associated with nephropathy in NIDDM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8835322     DOI: 10.1111/j.1399-0004.1995.tb04111.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  18 in total

Review 1.  APOE polymorphism and diabetic nephropathy.

Authors:  Shin-ichi Araki
Journal:  Clin Exp Nephrol       Date:  2013-09-13       Impact factor: 2.801

2.  Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis.

Authors:  Yang Li; Kefu Tang; Zhao Zhang; Ming Zhang; Zhen Zeng; Zangdong He; Lin He; Chunling Wan
Journal:  Mol Biol Rep       Date:  2010-02-24       Impact factor: 2.316

Review 3.  The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.

Authors:  Tingting Li; Yun Shi; Jieyun Yin; Qin Qin; Sheng Wei; Shaofa Nie; Li Liu
Journal:  Int Urol Nephrol       Date:  2014-09-28       Impact factor: 2.370

4.  Role of apolipoprotein E in renal damage protection.

Authors:  F Bonomini; L F Rodella; M Moghadasian; C Lonati; R Coleman; R Rezzani
Journal:  Histochem Cell Biol       Date:  2011-05-15       Impact factor: 4.304

5.  A retrospective study on the influence of apolipoprotein e and serum lipids in progressive renal failure.

Authors:  L Roussos; Peter-Nilsson Ehle; Claes-Henrik Florén
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

6.  The heparan sulfate proteoglycan gene polymorphism: association with type 2 diabetic nephropathy in Chinese.

Authors:  Limei Liu; Kunsan Xiang; Taishan Zheng; Rong Zhang; Ming Li; Yanqing Wang; Huijuan Lu; Jie Li
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

7.  Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.

Authors:  Sanjeev Sethi; Jeffrey D Gamez; Julie A Vrana; Jason D Theis; H Robert Bergen; Peter F Zipfel; Ahmet Dogan; Richard J H Smith
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

8.  Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients.

Authors:  Anne Julie Overgaard; Tine E Thingholm; Martin R Larsen; Lise Tarnow; Peter Rossing; James N McGuire; Flemming Pociot
Journal:  Clin Proteomics       Date:  2010-09-10       Impact factor: 3.988

9.  Protective role of the apolipoprotein E2 allele in age-related disease traits and survival: evidence from the Long Life Family Study.

Authors:  Alexander M Kulminski; Nalini Raghavachari; Konstantin G Arbeev; Irina Culminskaya; Liubov Arbeeva; Deqing Wu; Svetlana V Ukraintseva; Kaare Christensen; Anatoliy I Yashin
Journal:  Biogerontology       Date:  2016-07-22       Impact factor: 4.277

10.  Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study.

Authors:  Audrey Y Chu; Rulan S Parekh; Brad C Astor; Josef Coresh; Yvette Berthier-Schaad; Michael W Smith; Alan R Shuldiner; Wen Hong L Kao
Journal:  BMC Med Genet       Date:  2009-10-23       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.